Product Information
DONEPEZIL HCL 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0484 per EA under NDC 16571077950. Its NADAC has been published 250 times since Dec 22, 2021.
FDA first approved this application on May 31, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571077950
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090056FDA Approved
5/31/2011
TE Code
AB
On Market Since
5/31/2011
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL 10 MG TABLET has been published 250 times since Dec 22, 2021, and over the history we have for it it has risen 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0484 per EA |
|---|---|
| All-time high | $0.0541 (Mar 16, 2022) |
| All-time low | $0.0417 (May 22, 2024) |
| 52-week high | $0.0511 |
| 52-week low | $0.0475 |
| Median price | $0.0489 |
| Average price | $0.0488 |
| Largest weekly change | +16.1% (Aug 21, 2024) |
| Weeks tracked | 250 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Donepezil Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0484 per EA (NDC 16571077950), effective Sep 30, 2026.
How has the price of DONEPEZIL HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL 10 MG TABLET has risen 7.5%. It has been tracked across 250 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 10 MG TABLET?
Since Dec 22, 2021, the NADAC for DONEPEZIL HCL 10 MG TABLET has ranged from a low of $0.0417 (May 22, 2024) to a high of $0.0541 (Mar 16, 2022), with a median of $0.0489 per EA.
Are there cheaper alternatives to DONEPEZIL HCL 10 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DONEPEZIL HCL 10 MG TABLET?
DONEPEZIL HCL 10 MG TABLET (NDC 16571077950) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.